Borosil Scientific Ltd

Borosil Scientific Ltd

₹ 140 0.25%
30 May - close price
About

Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.[1]

Key Points

Borosil Group[1]
The company is a part of Borosil group which is into glassware and laboratory products,
scientific & industrial glassware, consumer & kitchenware products, and solar glass products. Group comprises of:
1. Borosil Renewables Ltd
2. Borosil Ltd
3. Borosil Scientific Ltd

  • Market Cap 1,242 Cr.
  • Current Price 140
  • High / Low 230 / 107
  • Stock P/E 35.5
  • Book Value 47.2
  • Dividend Yield 0.00 %
  • ROCE 12.0 %
  • ROE 8.72 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 2.96 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
91 80 84 88 103 93 87 94 118
72 73 72 75 84 82 74 82 96
Operating Profit 19 6 12 13 19 11 13 12 21
OPM % 21% 8% 15% 15% 18% 12% 15% 13% 18%
1 1 1 1 2 2 2 2 3
Interest 1 0 0 0 1 0 0 0 0
Depreciation 3 3 4 4 4 4 4 4 4
Profit before tax 17 4 10 10 16 9 11 9 20
Tax % 30% -15% 23% 28% 24% 25% 29% 28% 27%
12 4 8 7 12 6 8 7 14
EPS in Rs 0.84 1.36 0.73 0.87 0.75 1.59
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Mar 2025
323 352 392
272 301 334
Operating Profit 51 51 58
OPM % 16% 15% 15%
5 5 8
Interest 1 1 1
Depreciation 12 15 17
Profit before tax 43 40 48
Tax % 29% 21% 28%
30 31 35
EPS in Rs 3.54 3.94
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 12%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 11%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.29 9 9
Reserves 352 374 411
11 11 6
69 82 74
Total Liabilities 432 477 499
150 159 155
CWIP 8 1 1
Investments 32 41 146
241 275 197
Total Assets 432 477 499

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Mar 2025
-57 32 127
50 -20 -121
7 -1 -5
Net Cash Flow 0 11 1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Mar 2025
Debtor Days 46 55 59
Inventory Days 325 256 227
Days Payable 70 102 79
Cash Conversion Cycle 301 208 207
Working Capital Days 200 190 198
ROCE % 11% 12%

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025
67.92% 67.86% 67.84% 67.81%
0.38% 0.37% 0.27% 0.24%
0.15% 0.01% 0.02% 0.02%
31.54% 31.74% 31.88% 31.91%
No. of Shareholders 62,35461,20160,37358,894

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents